No association between the MDM2 -309 T/G promoter polymorphism and breast cancer in African-Americans or Whites.
Millikan
Robert C
RC
Department of Epidemiology, School of Public Health and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7435, USA. millikan@email.unc.edu
Heard
Kimberley
K
Winkel
Scott
S
Hill
Edgar J
EJ
Heard
Kristin
K
Massa
Beri
B
Mayes
Lydia
L
Williams
Patricia
P
Holston
Rachel
R
Conway
Kathleen
K
Edmiston
Sharon
S
de Cotret
Allan René
AR
D001741:Black or African American / Q000235:genetics*; D017668:Age of Onset; D000483:Alleles; D001943:Breast Neoplasms / Q000208:ethnology / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D005787:Gene Frequency; D016158:Genes, p53; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D009154:Mutation; D009657:North Carolina; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D011401:Promoter Regions, Genetic; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics*; D044465:White People / Q000235:genetics*
D051736:Proto-Oncogene Proteins c-mdm2